Congruence Therapeutics
About:
Congruence Therapeutics operates as a biotechnology company.
Website: https://congruencetx.com/
Top Investors: Fonds de solidarité FTQ, BDC Venture Capital, OrbiMed, Investissement Quebec, Amplitude Venture Capital
Description:
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
Total Funding Amount:
$64.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Montréal, Quebec, Canada
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-03-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai